The association between cutaneous vasculitis and decreased blood fibrinolytic activity.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001167:Arteritis / Q000097:blood; D001172:Arthritis, Rheumatoid / Q000097:blood; D004892:Erythema Multiforme / Q000097:blood; D004893:Erythema Nodosum / Q000097:blood; D005032:Ethylestrenol / Q000627:therapeutic use; D005260:Female; D005342:Fibrinolysis; D005356:Fibromyalgia / Q000097:blood; D006801:Humans; D007249:Inflammation; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000627:therapeutic use; D010859:Pigmentation Disorders / Q000097:blood; D010488:Polyarteritis Nodosa / Q000097:blood; D011693:Purpura / Q000097:blood; D012712:Serum Globulins; D012867:Skin / Q000098:blood supply*; D012871:Skin Diseases / Q000097:blood* / Q000188:drug therapy; D013197:Stanozolol / Q000627:therapeutic use; D014652:Vascular Diseases / Q000097:blood* / Q000188:drug therapy
D012712:Serum Globulins; D013197:Stanozolol; D005032:Ethylestrenol; D010629:Phenformin